Corneal Cross-Linking (CXL)
Ophthalmology
Starting from
$700
Up to $2,500 depending on centre
Typical duration
3–7 days
Including pre-operative work-up
Content reviewed for medical accuracy by: Dr. Rodina Ainasoa · Medical Content Writer & Health Communications
Overview
Corneal cross-linking (CXL) is a treatment to halt the progression of keratoconus and other corneal ectasias by strengthening the corneal collagen fibres using riboflavin (vitamin B2) eye drops and UV-A light. Unlike corneal transplantation, CXL does not replace or reshape the cornea — it stabilises it, aiming to stop further weakening and preserve remaining vision.
Your case is matched to a centre on the basis of clinical outcome data, not marketing. We coordinate every step — from pre-operative work-up to post-treatment follow-up — with a dedicated care coordinator.
What's included
Corneal Cross-Linking (CXL)
Indicative coordinated cost from
or message us on WhatsApp
No commitment required. Your information is shared only with authorised parties involved in your care coordination, subject to applicable privacy requirements.
Key insights at a glance
Starting from
$700
Up to $2,500 depending on centre
Typical duration
3–7 days
Including pre-operative work-up
Procedures
3
Hold to see procedures
Partner hospitals
0
Vetted for outcome data & accreditation
Epithelium-Off vs. Epithelium-On vs. Accelerated Cross-Linking
Corneal cross-linking (CXL) strengthens corneal collagen fibres with riboflavin (vitamin B2) drops and UV-A light to halt progressive keratoconus. Protocols differ in whether the corneal surface layer (epithelium) is removed and how quickly the UV light is delivered, which affects penetration, comfort, and recovery.
| Parameter | Epithelium-Off (Dresden Protocol) | Epithelium-On (Transepithelial) | Accelerated CXL |
|---|---|---|---|
| What it is | The corneal epithelium is removed before riboflavin is applied, allowing deeper drug penetration; this is the original, most-studied protocol, delivering UV-A at 3 mW/cm² for 30 minutes (5.4 J/cm² total dose). | The epithelium is left intact and riboflavin is formulated to cross it, avoiding epithelial removal but reducing how much riboflavin reaches the underlying stroma. | Delivers the same total UV-A energy dose as the standard protocol but at higher intensity over a shorter session, and can be combined with either an epithelium-off or epithelium-on approach. |
| Corneal penetration (demarcation line depth) | Produces a deeper corneal demarcation line (a marker of treatment depth) — one study measured a mean depth of around 220 micrometres at 3 months. | Produces a shallower demarcation line than epithelium-off — the same study measured a mean depth of around 127 micrometres — reflecting reduced riboflavin penetration. | Demarcation line depth with accelerated protocols is comparable within each epithelium-off or epithelium-on category, though generally shallower than the original slower Dresden protocol. |
| Comfort & visual recovery | Slower visual recovery and more post-treatment discomfort while the epithelium heals, typically over several days, per systematic review evidence. | Faster visual recovery, less postoperative pain, and a lower incidence of corneal haze than epithelium-off, per a systematic review and meta-analysis of the two approaches. | Recovery comfort follows the underlying epithelium-off or epithelium-on approach used, with the shorter UV session itself not materially changing comfort. |
| Effectiveness at halting progression | Despite deeper demarcation and slower recovery, epithelium-off CXL has the longest track record and demonstrated corneal thinning and flattening effect in halting keratoconus progression. | Both epithelium-off and epithelium-on approaches are effective at halting progressive keratoconus, though some reviews note epithelium-off shows a greater degree of corneal flattening and thinning. | Accelerated protocols aim to preserve the effectiveness of the slower protocol in a shorter session; your surgeon will weigh the evidence for your specific corneal thickness and progression pattern. |
| Best suited for | Patients with adequate corneal thickness who can tolerate a longer, more involved recovery in exchange for the most extensively studied protocol. | Patients prioritising comfort and faster return to normal activity, or those for whom epithelial removal carries added risk. | Patients and clinics seeking a shorter treatment session; suitability still depends on which underlying (epi-off or epi-on) approach is used. |
The Procedure: Step by Step
The steps below describe the general corneal cross-linking process. The specific protocol — epithelium-off, epithelium-on, or accelerated — is selected based on your corneal thickness, keratoconus severity, and surgeon assessment (see comparison above).
Pre-treatment evaluation
Corneal topography and pachymetry (thickness measurement) confirm progressive keratoconus and that your cornea is thick enough for safe treatment, per the American Academy of Ophthalmology (AAO).
Epithelium preparation
For epithelium-off protocols, the thin surface layer of the cornea is gently removed; epithelium-on protocols instead use a riboflavin formulation designed to cross the intact surface.
Riboflavin application
Riboflavin (vitamin B2) drops are applied to the cornea at set intervals to saturate the corneal stroma before UV exposure begins.
UV-A light exposure
The cornea is exposed to UV-A light — either at standard intensity for around 30 minutes or at higher intensity for a shorter accelerated session — which triggers new bonds (cross-links) between collagen fibres, strengthening the cornea, per Mayo Clinic.
Recovery Timeline
A bandage contact lens is often worn after epithelium-off treatment while the surface heals; discomfort, light sensitivity, and blurred vision are common in the first few days.
The corneal surface typically heals within about a week for epithelium-off protocols; epithelium-on patients generally experience a faster, more comfortable return to normal activity.
Vision can fluctuate as the cornea remodels; many patients notice gradual stabilisation of their prescription over the following months rather than an immediate change.
Follow-up corneal topography over 6–12 months confirms whether keratoconus progression has been halted, which is the primary treatment goal rather than immediate vision improvement.
Source: American Academy of Ophthalmology; Mayo Clinic; NCBI/PMC systematic review and meta-analysis of epithelium-on vs. epithelium-off corneal cross-linking. Individual recovery varies and is guided by your surgical team.
Known Risks & Limitations
- CXL is intended to stop keratoconus from worsening — it does not reliably reverse corneal steepening already present or guarantee improved unaided vision.
- Temporary corneal haze, light sensitivity, and discomfort are common in the days after epithelium-off treatment; infection risk, while uncommon, is higher when the epithelium is removed.
- Corneal thickness must be adequate for the chosen protocol; very thin corneas may not be candidates for standard treatment and may need an individualised, reduced-fluence approach.
- As with any procedure, individual healing and outcomes vary; a small proportion of patients may still show progression and require re-treatment or, ultimately, corneal transplantation.
- There is no robotic-assisted version of corneal cross-linking — it is a topical, light-based treatment rather than incisional surgery, so the relevant choice is between epithelium-off, epithelium-on, and accelerated UV protocols, not open-versus-robotic technique.
Source: American Academy of Ophthalmology; Mayo Clinic; NCBI/StatPearls. No procedure is without risk; your surgical team will review your individual risk factors.
The CureSureMedico Care Pathway
Remote clinical review
Share your corneal topography, pachymetry, and diagnosis history. Our coordination team forwards your case to a corneal specialist to confirm candidacy and recommend a protocol.
Protocol & clinic matching
Your partner centre confirms which protocol — epithelium-off, epithelium-on, or accelerated — suits your corneal thickness and progression pattern before your estimate is finalised.
Consolidated estimate
A cost estimate covering the treatment session, riboflavin, bandage contact lens where applicable, and initial follow-up is issued before you travel.
Treatment & short-stay recovery
CXL is typically a same-day outpatient treatment; your care team monitors initial healing and schedules a follow-up examination before you are cleared to travel home.
Continuity of care post-return
A treatment summary — including the protocol used and a topography follow-up schedule — is shared with your home ophthalmologist to confirm progression has been halted.
Global cost comparison — Corneal Cross-Linking (CXL)
Average coordinated costs across our partner centres. Final pricing depends on clinical complexity and chosen hospital.
| Country | Avg. cost | vs. cheapest |
|---|---|---|
🇮🇳 India New Delhi · Chennai · Bengaluru · Hyderabad · Mumbai · Kochi | $800 | —chevron_right |
🇹🇷 Turkey Istanbul | $1,400 | +75%chevron_right |
🇹🇭 Thailand Bangkok · Phuket · Chiang Mai | $2,000 | +150%chevron_right |
Costs are indicative estimates and vary by procedure specifics, hospital, and clinical complexity. Request a personalised estimate for your specific case.
Similar procedures
Cataract Surgery
Phacoemulsification cataract extraction with intraocular lens implantation — the world's most performed eye surgery — restores clear vision clouded by lens opacity. Leading centres abroad offer premium multifocal and toric IOLs at a fraction of Western costs, reducing dependence on glasses after surgery.
Starting from
$800
3–7 days
LASIK & Refractive Surgery
Laser vision correction permanently reshapes the cornea to eliminate the need for glasses or contact lenses in patients with myopia, hyperopia, and astigmatism. Accredited centres in India, Turkey, and Thailand offer LASIK, SMILE, and advanced surface ablation using the same FDA-cleared laser platforms as Western clinics at 50–70% lower cost.
Starting from
$800
3–5 days
Retinal Surgery
Vitreoretinal surgery addresses sight-threatening conditions at the back of the eye including retinal detachment, macular holes, epiretinal membranes, and severe diabetic eye disease. India, Israel, and Thailand host internationally trained vitreoretinal specialists offering timely, high-quality intervention at significantly reduced cost.
Starting from
$1,500
7–14 days
Corneal Transplant (Ophthalmic)
Corneal transplantation replaces diseased or damaged corneal tissue to restore clarity and vision in conditions like keratoconus, corneal scarring, and endothelial failure. Selective lamellar techniques (DALK, DSEK, DMEK) preserve healthy tissue and offer faster recovery than full-thickness grafts.
Starting from
$2,000
10–21 days
Frequently asked questions
CXL is primarily intended to halt the progression of keratoconus, not to reverse existing corneal steepening or restore vision already lost. Some patients experience a modest improvement in corneal shape and vision over the following months, but the main goal is stabilisation — preventing the need for a future corneal transplant. Your surgeon will set expectations based on your topography and how advanced your keratoconus is at the time of treatment.
Transparent fees. No commitment.
Clear, transparent guidance
CureSureMedico charges a transparent, fixed coordination fee to the patient or institutional payer. Treatment costs are billed directly by the partner hospital.